The adverse events profile of anti-IGF-1R monoclonal antibodies in cancer therapy

Por Ma, Honghai, Zhang, Tiehong, Shen, Hongchang, Cao, Hongxin, Du, Jiajun
Publicado em 2014

Lower Blood Calcium Associates with Unfavorable Prognosis and Predicts for Bone Metastasis in NSCLC

Por Shen, Hongchang, Li, Yongqiu, Liao, Yida, Zhang, Tiehong, Liu, Qi, Du, Jiajun
Publicado em 2012

Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma

Por Zhang, Tiehong, Shen, Hongchang, Dong, Wei, Qu, Xiao, Liu, Qi, Du, Jiajun
Publicado em 2014

Evaluation of Preoperative Hematologic Markers as Prognostic Factors and Establishment of Novel Risk Stratification in Resected pN0 Non-Small-Cell Lung Cancer

Por Zhang, Tiehong, Jiang, Yuanzhu, Qu, Xiao, Shen, Hongchang, Liu, Qi, Du, Jiajun
Publicado em 2014

Tumor-stroma ratio is an independent predictor for survival in NSCLC

Por Zhang, Tiehong, Xu, Jun, Shen, Hongchang, Dong, Wei, Ni, Yang, Du, Jiajun
Publicado no Int J Clin Exp Pathol (2015)

Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes

Por Liu, Hongfeng, Yan, Tao, Zhang, Tiehong, Chen, Xiaowei, Wang, Yadong, Du, Jiajun
Publicado no Medicine (Baltimore) (2019)

The Number of Resected Lymph Nodes (nLNs) Combined with Tumor Size as a Prognostic Factor in Patients with Pathologic N0 and Nx Non-Small Cell Lung Cancer

Por Yang, Miaomiao, Cao, Hongxin, Guo, Xi, Zhang, Tiehong, Hu, Pingping, Du, Jiajun, Liu, Qi
Publicado em 2013

Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort

Por Sun, Haifeng, Hu, Pingping, Shen, Hongchang, Dong, Wei, Zhang, Tiehong, Liu, Qi, Du, Jiajun
Publicado no PLoS One (2015)

Predictive Effects of Lung function test on Postoperative Pneumonia in Squamous Esophageal Cancer

Por Wei, Ran, Dong, Wei, Shen, Hongchang, Ni, Yang, Zhang, Tiehong, Wang, Yibing, Du, Jiajun
Publicado no Sci Rep (2016)

The Effect of Diabetes Mellitus on Lung Cancer Prognosis: A PRISMA-compliant Meta-analysis of Cohort Studies

Por Zhu, Linhai, Cao, Hongxin, Zhang, Tiehong, Shen, Hongchang, Dong, Wei, Wang, Liguang, Du, Jiajun
Publicado no Medicine (Baltimore) (2016)

Diagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis

Por Shen, Hongchang, Che, Keying, Cong, Lei, Dong, Wei, Zhang, Tiehong, Liu, Qi, Du, Jiajun
Publicado no Oncotarget (2017)

Long-term outcomes of stage I NSCLC (≤3 cm) patients following segmentectomy are equivalent to lobectomy under analogous extent of lymph node removal: a PSM based analysis

Por Qu, Xiao, Wang, Kai, Zhang, Tiehong, Shen, Hongchang, Dong, Wei, Liu, Qi, Du, Jiajun
Publicado no J Thorac Dis (2017)

Invasion Types Are Associated With Poor Prognosis in Lung Squamous Carcinoma Patients

Por Zhao, Yang, Shen, Hongchang, Qiu, Chen, Zhang, Tiehong, Hu, Pingping, Qu, Xiao, Liu, Qi, Du, Jiajun
Publicado no Medicine (Baltimore) (2015)

Prognostic significance of tumor budding and single cell invasion in gastric adenocarcinoma

Por Che, Keying, Zhao, Yang, Qu, Xiao, Pang, Zhaofei, Ni, Yang, Zhang, Tiehong, Du, Jiajun, Shen, Hongchang
Publicado no Onco Targets Ther (2017)

Prognostic effects of preoperative obstructive pneumonitis or atelectasis and comparison with tumor size in non-small cell lung cancer

Por Pang, Zhaofei, Ding, Nan, Dong, Wei, Ni, Yang, Zhang, Tiehong, Qu, Xiao, Du, Jiajun, Liu, Qi
Publicado no J Thorac Dis (2017)

Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapy

Por Qu, Xiao, Wu, Zhinan, Dong, Wei, Zhang, Tiehong, Wang, Liguang, Pang, Zhaofei, Ma, Wei, Du, Jiajun
Publicado no Oncotarget (2017)

Subcellular localization of β-arrestin1 and its prognostic value in lung adenocarcinoma

Por Li, Xiaowei, Che, Keying, Wang, Liguang, Zhang, Tiehong, Wang, Guanghui, Pang, Zhaofei, Shen, Hongchang, Du, Jiajun
Publicado no Medicine (Baltimore) (2017)

Optimal managements of stage IIIA (N2) non-small cell lung cancer patients: a population-based survival analysis

Por Pang, Zhaofei, Yang, Yufan, Ding, Nan, Huang, Cuicui, Zhang, Tiehong, Ni, Yang, Du, Jiajun, Liu, Qi
Publicado no J Thorac Dis (2017)

Effects of postoperative non-steroidal anti-inflammatory drugs on long-term survival and recurrence of patients with non-small cell lung cancer

Por Jiang, Wensheng, Wang, Liguang, Zhang, Jiangang, Shen, Hongchang, Dong, Wei, Zhang, Tiehong, Li, Xiaowei, Wang, Kai, Du, Jiajun
Publicado no Medicine (Baltimore) (2018)

ARRB1 enhances the chemosensitivity of lung cancer through the mediation of DNA damage response

Por Shen, Hongchang, Wang, Liguang, Zhang, Jiangang, Dong, Wei, Zhang, Tiehong, Ni, Yang, Cao, Hongxin, Wang, Kai, Li, Yun, Wang, Yibing, Du, Jiajun
Publicado no Oncol Rep (2017)